285 related articles for article (PubMed ID: 35223996)
1. N6-Methyladenosine Methylation Regulator RBM15 is a Potential Prognostic Biomarker and Promotes Cell Proliferation in Pancreatic Adenocarcinoma.
Zhao Z; Ju Q; Ji J; Li Y; Zhao Y
Front Mol Biosci; 2022; 9():842833. PubMed ID: 35223996
[TBL] [Abstract][Full Text] [Related]
2. Identifies microtubule-binding protein
Wang W; Zhang J; Wang Y; Xu Y; Zhang S
Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625
[TBL] [Abstract][Full Text] [Related]
3. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.
Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y
J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer.
Zhang C; Gu L; Xiao J; Jin F
BMC Cancer; 2023 Jul; 23(1):684. PubMed ID: 37474926
[TBL] [Abstract][Full Text] [Related]
6. RBM15 facilities lung adenocarcinoma cell progression by regulating RASSF8 stability through N6 Methyladenosine modification.
Ma M; Wang W; Li L; Wang X; Huang Q; Zhou C; Huang Y; Zhao G; Ye L
Transl Oncol; 2024 Jun; 46():102018. PubMed ID: 38838436
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of N6-methyladenosine RBM15 regulators in lung adenocarcinoma.
Ma M; Wang W; Wang B; Yang Y; Huang Y; Zhao G; Ye L
Cell Mol Biol (Noisy-le-grand); 2022 May; 68(1):130-139. PubMed ID: 35809319
[TBL] [Abstract][Full Text] [Related]
8. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract][Full Text] [Related]
9. Systematic analysis of the oncogenic role of FAM83D across cancers based on data mining.
Geng Y; Liu J; Wang Z; Liu T; Peng X; Huang Y
Cell Cycle; 2023 Apr; 22(8):1005-1019. PubMed ID: 36710419
[TBL] [Abstract][Full Text] [Related]
10. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression.
Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X
Front Oncol; 2022; 12():927988. PubMed ID: 35756681
[TBL] [Abstract][Full Text] [Related]
11. N6-methyladenosine methylation regulator RBM15 promotes the progression of diabetic nephropathy by regulating cell proliferation, inflammation, oxidative stress, and pyroptosis through activating the AGE-RAGE pathway.
Qin Y; Wu S; Zhang F; Zhou X; You C; Tan F
Environ Toxicol; 2023 Nov; 38(11):2772-2782. PubMed ID: 37551785
[TBL] [Abstract][Full Text] [Related]
12. Knockdown RBM15 Inhibits Colorectal Cancer Cell Proliferation and Metastasis Via N6-Methyladenosine (m6A) Modification of MyD88 mRNA.
Zhang Z; Mei Y; Hou M
Cancer Biother Radiopharm; 2022 Dec; 37(10):976-986. PubMed ID: 34842457
[TBL] [Abstract][Full Text] [Related]
13. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
14. NFE2L2 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltration in Brain Lower Grade Glioma: A Pan-Cancer Analysis.
Ju Q; Li X; Zhang H; Yan S; Li Y; Zhao Y
Oxid Med Cell Longev; 2020; 2020():3580719. PubMed ID: 33101586
[TBL] [Abstract][Full Text] [Related]
15.
Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
Front Immunol; 2022; 13():805311. PubMed ID: 35154122
[TBL] [Abstract][Full Text] [Related]
16. PEX13 is a potential immunotherapeutic indicator and prognostic biomarker for various tumors including PAAD.
Dong P; Du X; Yang T; Li D; Du Y; Wei Y; Sun J
Oncol Lett; 2023 Dec; 26(6):512. PubMed ID: 37920431
[TBL] [Abstract][Full Text] [Related]
17. Enhancing m
Huang Y; Lv Y; Yang B; Zhang S; Bixia Liu ; Zhang C; Hu W; Jiang L; Chen C; Ji D; Xiong C; Liang Y; Liu M; Ying X; Ji W
Heliyon; 2024 Apr; 10(7):e28165. PubMed ID: 38560117
[TBL] [Abstract][Full Text] [Related]
18. TLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer.
Zou X; Guo Y; Mo Z
Front Genet; 2022; 13():905988. PubMed ID: 36419829
[No Abstract] [Full Text] [Related]
19. RBM15 Promates the Proliferation, Migration and Invasion of Pancreatic Cancer Cell Lines.
Dong H; Zhang H; Mao X; Liu S; Xu W; Zhang Y
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831430
[TBL] [Abstract][Full Text] [Related]
20. BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis.
Ju Q; Li XM; Zhang H; Zhao YJ
Front Mol Biosci; 2020; 7():573619. PubMed ID: 33240929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
